[
    {
        "TermId": 1234,
        "Language": "EN",
        "Dictionary": "Dictionary",
        "Audience": "Patient",
        "TermName": "TermName",
        "FirstLetter": "t",
        "PrettyUrlName": "www.glossary-api.com",
        "Pronunciation": {
            "Key": "Pronunciation Key",
            "Audio": "pronunciation"
        },
        "Definition": {
            "Html": "<html><h1>Definition</h1></html>",
            "Text": "Sample definition"
        },
        "OtherLanguages": [],
        "RelatedResources": [
            {
                "Url": "https://www.google.com",
                "Type": "External",
                "Text": "Link to Google"
            },
            {
                "Url": "https://www.cancer.gov/about-cancer/treatment/drugs/bevacizumab",
                "Type": "DrugSummary",
                "Text": "Bevacizumab"
            },
            {
                "Url": "https://www.cancer.gov/types/lung/patient/small-cell-lung-treatment-pdq",
                "Type": "Summary",
                "Text": "Lung cancer treatment"
            },
            {
                "Type": "GlossaryTerm",
                "Text": "stage II cutaneous T-cell lymphoma",
                "TermId": 43966,
                "Audience": "Patient",
                "PrettyUrlName": "stage-ii-cutaneous-t-cell-lymphoma"
            }
        ],
        "Media":[]
    }
]